Cleared Traditional

K113225 - NYLUS PICC

K113225 is an FDA 510(k) clearance for NYLUS PICC, manufactured by Semprus Biosciences. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 371-day FDA review.

K113225 · Semprus Biosciences · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
371d
Days
Class 2
Risk

K113225 is an FDA 510(k) clearance for the NYLUS PICC. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Semprus Biosciences (Cambridge, US). The FDA issued a Cleared decision on November 6, 2012 after a review of 371 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Semprus Biosciences devices

FDA 510(k) Submission Details - K113225

510(k) Number K113225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2011
Decision Date November 06, 2012
Days to Decision 371 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
242d slower than avg
Panel avg: 129d · This submission: 371d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 213
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K113225.
NMI PICC MAXIMAL BARRIER NURSING KITS
K131038 · Navilyst Medical, Inc. · May 2013
CG+ ARROW PICC POWERED BY ARROW VPS STYLET
K130876 · Arrow International, Inc. · Apr 2013
VASU-PICC
K122423 · Medical Components, Inc. · Dec 2012
NMI HPICC III
K122882 · Navilyst Medical, Inc. · Oct 2012
NMI PICC III
K121089 · Navilyst Medical, Inc. · Aug 2012
PICC CONVENIENCE KIT
K121990 · Navilyst Medical, Inc. · Aug 2012